A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
With a diverse healthcare network and renowned medical research institutions, Arizona is a key player in clinical research. Leading clinical research organizations such as the Mayo Clinic in Phoenix, Banner Health, University of Arizona Health Sciences, and the Translational Genomics Research Institute (TGen) are driving medical research and innovation advancements. These institutions are at the forefront of clinical studies, contributing significantly to cutting-edge treatments and healthcare advancements across the state.
Why choose Arizona for clinical trials?
Participating in clinical trials in Arizona offers several unique advantages. First, due to the state being home to some of the nation's top research institutions, participants have access to cutting-edge treatments and advanced medical care. These institutions are leaders in fields like oncology, cardiology, and precision medicine, allowing participants to be at the forefront of groundbreaking medical advancements.
Another significant advantage is Arizona's diverse population, which allows for a broad range of clinical trials addressing different demographics and health conditions. This diversity increases the relevance of clinical trial outcomes across varied populations, ensuring more accurate and inclusive medical research. Additionally, Arizona’s pleasant climate and growing healthcare infrastructure make participation in trials more convenient and accessible, especially for those traveling to Phoenix or Tucson for care.
Common conditions studied in Arizona
In Arizona, clinical trials commonly focus on conditions that are prevalent in the state and the broader U.S. Southwest region.
Diabetes and metabolic disorders
Arizona has a higher-than-average prevalence of diabetes, particularly among its Native American and Hispanic populations. Clinical trials in this area focus on new medications, lifestyle interventions, self-management, holistic therapies, and technologies like insulin delivery systems.
Several research institutions in Arizona are currently carrying out clinical trials for diabetes including the Mayo Clinic, Banner Health, and the Phoenix Indian Medical Center. The University of Arizona Health Sciences in Tucson also plays a significant role in diabetes research. Through its partnerships with the College of Medicine, College of Pharmacy, and other departments, UAHS is involved in clinical trials and research initiatives targeting type 1, type 2, and gestational diabetes.
Cancer
With renowned research institutions like the Mayo Clinic and the University of Arizona Cancer Center, oncology is a major focus for clinical research teams in Arizona. Researchers study a wide range of cancers here, including breast, lung, skin (melanoma), and prostate cancers, among others. Arizona’s aging population makes cancer research especially relevant.
Oncology clinical trials in Arizona offer access to innovative treatments for participants, such as new medications, immunotherapies, and advanced treatment techniques that are not yet widely available.
Interested in learning more about how clinical trials for cancer work? Explore our guide to better understand oncology clinical trials and how they contribute to advancing cancer treatments.
Respiratory diseases
Given Arizona’s dry climate and high levels of dust and pollen, respiratory conditions like asthma, chronic obstructive pulmonary disease (COPD), and valley fever (coccidioidomycosis) are also frequently studied in clinical trials. With its unique environment and healthcare infrastructure, Arizona is an important hub for respiratory disease research.
Cardiovascular disease
Heart disease is the leading cause of death in Arizona, meaning the state places a large emphasis on clinical research trials for cardiovascular conditions. These often explore innovative treatments for conditions such as heart failure, hypertension, and atrial fibrillation.
Institutions like the Banner University Medical Center and the Arizona Heart Institute are committed to improving preventative measures for this prevalent condition, as well as developing new treatments to combat it. The main goal of many research trials here is to reduce the impact of cardiovascular disease on millions of Arizona residents, as well as the wider population.
Current innovations being tested in Arizona include gene therapy, regenerative medicine, stem cell therapy, minimally invasive valve replacement, and advanced medical devices for heart failure.
Neurological disorders
Conditions such as Alzheimer's disease, Parkinson's disease, strokes, and multiple sclerosis (MS) are also common areas of study in Arizona. The state is home to research centers like Barrow Neurological Institute, which is one of the world’s leading centers for research and treatment of neurological conditions. This center leads clinical trials on treatments and therapies for these diseases and is also known for its advanced surgical treatments.
Several key innovations in neurological disorders are currently being tested in clinical trials in Arizona, including gene therapy, precision medicine, stem cell therapy, deep brain stimulation, immunotherapy, wearable devices, and regenerative medicine. These cutting-edge approaches aim to improve diagnosis, treatment, and overall quality of life for patients.
Local regulations and guidelines
Clinical trials in Arizona are governed by a combination of federal, state, and local regulations designed to ensure the safety, ethical treatment, and privacy of participants. While Arizona’s clinical trial regulations mostly follow federal guidelines, there are also some state-specific considerations including informed consent for minors and vulnerable populations, medical marijuana research guidelines, and pharmacy board oversight.
Before any clinical trial can commence in Arizona, it must be reviewed and approved by an Institutional Review Board (IRB). IRBs must ensure clinical trials meet ethical standards and comply with federal and state regulations, including gaining informed consent, maintaining confidentiality, and monitoring participant safety. Clinical trials conducted in Arizona are also often required to be registered with ClinicalTrials.gov, a federal database where trial protocols and results are publicly accessible.
Benefits of participating in clinical trials
Joining a clinical trial provides a range of advantages, such as the opportunity to receive innovative treatments and therapies before they are widely accessible. Participants benefit from close supervision by leading healthcare professionals who offer specialized attention and care throughout the study.
Furthermore, taking part in clinical trials helps drive crucial medical research that could lead to new breakthroughs in treatment for future patients. By participating, individuals not only gain early exposure to cutting-edge medical options but also contribute to the progress of science, helping to improve healthcare for others.
How to enroll in a clinical trial in Arizona
Enrolling in a clinical trial through our platform is a straightforward and user-friendly process. Here's how to get started:
- Identify your trial: Use our intuitive search bar or filter options to locate clinical trials specific to requirements. This first step simplifies the process of finding relevant research studies tailored to your needs.
- Select your preferred location: To find trials conveniently located near you, simply input your preferred location into the dedicated filter bar on the left-hand side of the page.
- Explore study details: For in-depth information about each study, simply click the “Learn More” button. This will provide you with comprehensive details about the trial, including objectives, procedures, and eligibility criteria.
- Complete the health profile: After clicking on the “Get started” button you will be taken to our efficient 5-step application process to provide important health information. This helps us match you with the clinical trial that best fits your needs.
- Submit the application: After completing the application, send it in. A clinical trial coordinator will review it and contact you regarding the possibility of participation.